Find a Doctor

Junya Kanda

Kyoto University
Female

Bio


Junya Kanda is in Kyoto, Japan. They have been an author on 194 peer reviewed articles in the past 15 years.

Contact

Kyoto, JP

Latest Advances


Latest Advance
Study
  • Condition: Transplant-associated Thrombotic Microangiopathy
  • Journal: Blood advances
  • Treatment Used: Various
  • Number of Patients: 2425
  • Published —
In this study, researchers sought to determine the best treatment for transplant-associated thrombotic microangiopathy.
Latest Advance
Study
  • Condition: Cytogenetically Intermediate-Risk Acute Myeloid Leukemia (AML)
  • Journal: International journal of hematology
  • Treatment Used: Chemotherapy
  • Number of Patients: 235
  • Published —
This study investigated the use of patient mutations to determine the efficacy of chemotherapy for patients with cytogenetically intermediate-risk (AML).
Latest Advance
Study
  • Condition: diffuse large B-cell lymphoma
  • Journal: Annals of hematology
  • Treatment Used: allogeneic stem cell transplantation
  • Number of Patients: 68
  • Published —
The purpose of the study was to determine treatment outcomes of allogeneic stem cell transplantation for diffuse large B-cell lymphoma in the Kyoto Stem Cell Transplantation Group.
Latest Advance
Study
  • Condition: Acute myeloid leukemia
  • Journal: Annals of hematology
  • Treatment Used: Allogeneic hematopoietic cell transplantation
  • Number of Patients: 192
  • Published —
The study researched the effects of taking stem cells (cells that create more cells to replace damaged cells) and placing them in patients with acute myeloid leukemia.
Latest Advance
Study
  • Condition: Patients with Hematological Malignancies
  • Journal: Bone marrow transplantation
  • Treatment Used: Low-Dose Total Body Irradiation (TBI) in HLA-Mismatched Reduced-Intensity Stem Cell Transplantation (RICT)
  • Number of Patients: 575
  • Published —
This study evaluated the impact of low-dose total body irradiation (TBI) in patients with hematological malignancies who received first reduced-intensity conditioning stem cell transplantation (RICT) from ?1 antigen-mismatched donors.
Latest Advance
Study
  • Condition: Advanced Hematological Disease
  • Journal: European journal of haematology
  • Treatment Used: Haploidentical Transplantation Using Low-dose Thymoglobulin Versus Low-dose Alemtuzumab
  • Number of Patients: 14
  • Published —
In this study, researchers compared the effectiveness of haploidentical transplantation using low-dose thymoglobulin versus low-dose alemtuzumab for the treatment of
Latest Advance
Study
  • Condition: Hematopoietic Cell Transplantation (HCT)
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: Peripheral Blood (PB) vs. Bone Marrow (BM) from Unrelated Donors
  • Number of Patients: 5200
  • Published —
This study compared peripheral blood (PB) and bone marrow (BM) from unrelated donors as a graft source for hematopoietic cell transplantation (HCT).
Latest Advance
Study
  • Condition: Acute Myeloid Leukemia
  • Journal: British journal of haematology
  • Treatment Used: Allogeneic Haematopoietic Cell Transplantation
  • Number of Patients: 1080
  • Published —
This study investigated the clinical outcomes of adults with acute myeloid leukemia that were treated with cell transplantation.
Latest Advance
Study
  • Condition: Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM) in HIV-Positive Patients
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: Autologous Peripheral Blood Stem Cell Transplantation
  • Number of Patients: 6532
  • Published —
In this study, researchers evaluated the safety and effectiveness of performing autologous stem cell transplantation (ASCT) for HIV-positive patients with either non-Hodgkin lymphoma (NHL) or multiple myeloma (MM).

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Kyoto, JP

Insurance

Contact them to find out if they accept your insurance plan.